EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating Lipodystrophy: Insights from Laminopathies and Beyond

Peter Krüger, Ramona Hartinger, Karima Djabali iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158020 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Peter Krüger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical Uni…. Hauptthemen laut MEDLINE: Lamin Type A, Lipodystrophy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 294 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent research into laminopathic lipodystrophies—rare genetic disorders caused by mutations in the LMNA gene—has greatly expanded our knowledge of their complex pathology and metabolic implications. These disorders, including Hutchinson-Gilford progeria syndrome (HGPS), Mandibuloacral Dysplasia (MAD), and Familial Partial Lipodystrophy (FPLD), serve as crucial models for studying accelerated aging and metabolic dysfunction, enhancing our understanding of the cellular and molecular mechanisms involved. Research on laminopathies has highlighted how LMNA mutations disrupt adipose tissue function and metabolic regulation, leading to altered fat distribution and metabolic pathway dysfunctions. Such insights improve our understanding of the pathophysiological interactions between genetic anomalies and metabolic processes. This review merges current knowledge on the phenotypic classifications of these diseases and their associated metabolic complications, such as insulin resistance, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome, all of which elevate the risk of cardiovascular disease, stroke, and diabetes. Additionally, a range of published therapeutic strategies, including gene editing, antisense oligonucleotides, and novel pharmacological interventions aimed at addressing defective adipocyte differentiation and lipid metabolism, will be explored. These therapies target the core dysfunctional lamin A protein, aiming to mitigate symptoms and provide a foundation for addressing similar metabolic and genetic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lamin Type ALipodystrophyHumansAnimalsLaminopathiesProgeriaMutationLipodystrophy, Familial PartialLipid MetabolismAdipose TissueInsulin ResistanceGene Editing

Stichwörter der Autor:innen

Hutchinson-Gilford progeria syndrome (HGPS)adipose tissueagingfamilial partial lipodystrophy (FPLD)lamin Alipodystrophymandibuloacral dysplasia (MAD)metabolic syndrome

Substanzen

Lamin Type ALMNA protein, human

Autor:innen und Institutionen

  • Epigenetics of Aging, Department of Dermatology and Allergy, TUM School of Medicine, Munich Institute of Biomedical Engineering (MIBE), Technical University of Munich (TUM), 85748 Garching, Germany.

ORCID-Profile: Karima Djabali

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Krüger, P., Hartinger, R., & Djabali, K. (2024). Navigating Lipodystrophy: Insights from Laminopathies and Beyond. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158020

Vancouver

Krüger P, Hartinger R, Djabali K. Navigating Lipodystrophy: Insights from Laminopathies and Beyond. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158020

BibTeX
@article{Krger2024,
  author = {Krüger, Peter and Hartinger, Ramona and Djabali, Karima},
  title = {Navigating Lipodystrophy: Insights from Laminopathies and Beyond},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158020}
}
Kostenlos starten →